Skip to content
This website is intended for US healthcare professionals only.
Contact Us
Contact BioCryst
Submit an Inquiry
Request a Grant or Sponsorship
Expanded-Access Program
Search Medical Information
Clinical Trials
Congresses
Publications
Disease State Information & Resources
Hereditary Angioedema (HAE)
HAE Overview
HAE Video Library
Netherton Syndrome (NS)
Complement-Mediated Diseases
Clinical Trials
Congresses
Publications
Disease State Information & Resources
Hereditary Angioedema (HAE)
HAE Overview
HAE Video Library
Netherton Syndrome (NS)
Complement-Mediated Diseases
Contact Us
Contact BioCryst
Submit an Inquiry
Request a Grant or Sponsorship
Expanded-Access Program
Search Medical Information
Final results from ALPHA-STAR, a Phase 1b/2 Trial of navenibart in hereditary angioedema
View Article
biocryst
February 18, 2026
Hereditary Angioedema (HAE)
Attack rate reductions following berotralstat initiation among US patients with hereditary angioedema in the real-world
View Article
biocryst
February 5, 2026
Hereditary Angioedema (HAE)
Safety and pharmacokinetics of long-acting plasma kallikrein inhibitor navenibart (STAR-0215) in healthy adults
View Article
biocryst
February 5, 2026
Hereditary Angioedema (HAE)
STAR-0215 is a Novel, Long-Acting Monoclonal Antibody Inhibitor of Plasma Kallikrein for the Potential Treatment of Hereditary Angioedema
View Article
biocryst
February 5, 2026
Hereditary Angioedema (HAE)
Adherence and persistence among patients with hereditary angioedema receiving long-term prophylaxis in the United States
View Article
biocryst
January 9, 2026
Hereditary Angioedema (HAE)
Berotralstat effectiveness and safety in patients with hereditary angioedema with normal C1 inhibitor
View Article
biocryst
November 24, 2025
Hereditary Angioedema (HAE)
Reductions in medical visits and hospitalizations following berotralstat initiation in patients with hereditary angioedema in the United States
View Article
biocryst
November 24, 2025
Hereditary Angioedema (HAE)
Berotralstat for long-term prophylaxis of hereditary angioedema in Japan: Parts 2 and 3 of the randomized APeX-J Phase III trial
View Article
biocryst
February 12, 2025
Hereditary Angioedema (HAE)
Assessment of HAE prophylaxis transition from androgen therapy to berotralstat: A subset analysis of the APeX-S trial
View Article
biocryst
February 12, 2025
Hereditary Angioedema (HAE)
The Multifactorial Impact of Receiving a Hereditary Angioedema Diagnosis
View Article
biocryst
February 12, 2025
Hereditary Angioedema (HAE)
1
2
3
…
9
Next Page
